The probability of locoregional control in patients with locoregional recurrent breast cancer treated with postoperative re-irradiation and hyperthermia (RADHY): A continuous thermal dose-effect relationship

医学 热疗 乳腺癌 辐照 癌症 肿瘤科 泌尿科 内科学 物理 核物理学
作者
C. Paola Tello Valverde,A. Bakker,H. Petra Kok,M. Willemijn Kolff,Geertjan van Tienhoven,Polychronis Kostoulas,Prof Ben J Slotman,Konstantinos Pateras,Johannes Crezee
出处
期刊:International Journal of Radiation Oncology Biology Physics [Elsevier BV]
卷期号:122 (5): 1166-1174 被引量:2
标识
DOI:10.1016/j.ijrobp.2025.02.040
摘要

Mild hyperthermia (HT) (39-43 °C) combined with reirradiation is considered for patients with locoregional recurrent (LRR) breast cancer. Studies analyzing dichotomized HT thermal dose (TD) parameters suggest that higher TD correlates with better response rates, but evidence quantifying optimal TD levels needed to achieve locoregional control (LRC) is limited. We investigated the continuous TD-effect relationship of LRC in patients with LRR breast cancer treated with postoperative reirradiation and HT. In this historical cohort study, 112 patients with LRR breast cancer were treated in 2010-2017 with postoperative reirradiation 8 × 4 Gy (n = 34) or 23 × 2 Gy (n = 78) and 4 to 5 weekly HT sessions, TD was measured using invasive thermometry in the target region. Primary endpoint was the estimated probability of LRC at 5-years. The logarithm of highest ("Best") CEM43T50 (median cumulative equivalent minutes at 43 °C) of all HT sessions was analyzed as TD parameter based on Weibull univariate and stepwise multivariate regression analyses. Additionally, the best fitted Bayesian LRC survival model was analyzed assuming 3 informative priors: age, tumor location (breast/chest wall), and lymph node involvement. Twenty-four patients developed an infield recurrence; median time to recurrence was 3.4 years (interquartile range, 2.7-4.6 years). Increasing median Best session CEM43T50 TD range from 0.08 to 101.9 minutes was associated with increasing probability of LRC from ∼44% to 94% at 5-years, and over this range a 2-fold TD increase resulted in ∼5% to 10% increasing LRC. The hazard ratio for a subsequent recurrence decreased 48% (95% confidence interval, 18%-84%) with a 2-fold increase in TD over the TD range, P = .001. This effect was confirmed in Weibull multivariate regression analysis and in Bayesian LRC survival regression analysis. Increasing TD was strongly associated with an improved LRC, showing that adequate TD must be ensured and confirming that HT is essential for strongly sensitizing efficacy of postoperative reirradiation for patients with LRR breast cancer.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
miemie发布了新的文献求助10
刚刚
刚刚
1秒前
nice完成签到,获得积分10
1秒前
所所应助大气向雪采纳,获得10
2秒前
chongtse完成签到,获得积分10
2秒前
lin完成签到,获得积分10
2秒前
李庆完成签到,获得积分10
2秒前
漂亮天真完成签到,获得积分10
3秒前
dengty发布了新的文献求助10
4秒前
科研通AI6.2应助谨慎的炳采纳,获得10
5秒前
石武完成签到,获得积分10
5秒前
wang完成签到,获得积分10
5秒前
7秒前
8秒前
yier发布了新的文献求助10
8秒前
汉堡包应助眼睛大尔白采纳,获得10
9秒前
ceey_123完成签到,获得积分10
10秒前
10秒前
阳光的梦寒完成签到 ,获得积分10
10秒前
温暖的莞发布了新的文献求助10
11秒前
邓焕然发布了新的文献求助10
11秒前
在水一方应助txy采纳,获得10
12秒前
小枝完成签到,获得积分10
13秒前
共享精神应助科研通管家采纳,获得10
13秒前
大模型应助科研通管家采纳,获得10
13秒前
13秒前
侯人雄应助科研通管家采纳,获得10
13秒前
13秒前
sly发布了新的文献求助10
13秒前
13秒前
kokona11完成签到,获得积分20
14秒前
领导范儿应助科研通管家采纳,获得10
14秒前
14秒前
情怀应助科研通管家采纳,获得10
14秒前
侯人雄应助科研通管家采纳,获得10
14秒前
在水一方应助科研通管家采纳,获得10
14秒前
FashionBoy应助科研通管家采纳,获得20
14秒前
14秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
晶种分解过程与铝酸钠溶液混合强度关系的探讨 8888
Chemistry and Physics of Carbon Volume 18 800
The Organometallic Chemistry of the Transition Metals 800
Leading Academic-Practice Partnerships in Nursing and Healthcare: A Paradigm for Change 800
The formation of Australian attitudes towards China, 1918-1941 640
Signals, Systems, and Signal Processing 610
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 化学工程 生物化学 计算机科学 物理 内科学 复合材料 催化作用 物理化学 光电子学 电极 细胞生物学 基因 无机化学
热门帖子
关注 科研通微信公众号,转发送积分 6430882
求助须知:如何正确求助?哪些是违规求助? 8246789
关于积分的说明 17537773
捐赠科研通 5487314
什么是DOI,文献DOI怎么找? 2896007
邀请新用户注册赠送积分活动 1872507
关于科研通互助平台的介绍 1712296